You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

PET Imaging in Anal Canal Cancer

ID: PET 17 jan 2017
Type of Content: Guidelines & Advice, Evidence Summary
Document Status: Current
Authors:
A. Mahmud, R. Poon, D. Jonker

Guideline Objective

To provide a synthesis and summary of evidence surrounding the clinical utility of positron emission tomography (PET) imaging in patients with anal canal cancer.

Patient Population

Adult patients diagnosed with anal canal cancer.

Intended Guideline Users

This recommendation report is intended to guide the Ontario PET Steering Committee in their decision making with respect to the development of indications. This recommendation report may also be useful to inform clinicians who are involved in the management of patients with anal canal cancer.

Research Questions

  • What benefit to clinical management does PET or PET/CT contribute to the initial staging of anal canal cancer?
  • What benefit to clinical management does PET or PET/CT contribute to the assessment of treatment response of anal canal cancer?
  • What benefit to clinical management does PET or PET/CT contribute when the recurrence of anal canal cancer is suspected or proven?
pdf download Summary (PDF) (149.9 Ko)
pdf download Full Report (PDF) (508.27 Ko)